TMO Company Profile and Key Details

Q: Who are the executives of TMO?

Mr. Gianluca PettitiExecutive Vice PresidentMr. Joseph R. HolmesVice President & Chief Accounting OfficerMs. Sandy B. PoundVice President & Chief Communications OfficerDr. Karen E. Nelson Ph.D.Chief Scientific Officer & Member of Scientific Advisory BoardMr. Ryan J. SnyderSenior Vice President & Chief Information OfficerMr. Rafael TejadaVice President of Investor RelationsMr. Marc N. CasperChairman, Pres & Chief Executive OfficerMr. Stephen WilliamsonSenior Vice President & Chief Financial OfficerMr. Michel LagardeExecutive Vice President & Chief Operating OfficerMr. Michael A. Boxer Esq.Senior Vice President & Gen. Counsel

NYSE : TMO

Thermo Fisher Scientific

$542.36

-22.86-4.04%

At Close 4:00 PM

64.49

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Thermo Fisher Scientific Inc. (TMO) stock declined over -4.04%, trading at $542.36 on NYSE, down from the previous close of $565.22. The stock opened at $563.73, fluctuating between $541.34 and $566.83 in the recent session.

Stock Snapshot

565.22

Prev. Close

203.77B

Market Cap

541.34

Day Low

31.85

P/E Ratio

17.03

EPS (TTM)

19.79

Cash Flow per Share

563.73

Open

375.71M

Number of Shares

566.83

Day High

99.77%

Free Float in %

119.12

Book Value

3.22M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	563.73	566.83	541.34	542.36	3.22M
Feb 04, 2026	571.51	576.28	562.92	565.22	2.74M
Feb 03, 2026	580.00	588.85	566.41	570.09	2.16M
Feb 02, 2026	575.90	584.10	573.31	581.77	1.78M
Jan 30, 2026	581.73	585.95	574.23	578.61	3.69M
Jan 29, 2026	585.80	596.35	572.21	592.16	3.95M
Jan 28, 2026	618.64	620.60	606.32	608.02	2.34M
Jan 27, 2026	621.62	629.32	618.00	623.91	1.64M
Jan 26, 2026	625.34	633.65	623.23	626.62	1.73M
Jan 23, 2026	637.68	639.20	622.68	625.98	2.84M
Jan 22, 2026	637.39	643.99	634.81	639.45	2.61M
Jan 21, 2026	622.29	637.98	620.27	636.30	3.18M
Jan 20, 2026	609.50	620.85	606.00	619.01	3.11M
Jan 16, 2026	624.09	629.73	618.71	618.72	2.87M
Jan 15, 2026	619.97	629.87	618.61	624.65	2.53M
Jan 14, 2026	608.63	622.72	607.10	621.83	2.46M
Jan 13, 2026	613.32	620.22	594.30	607.08	2.84M
Jan 12, 2026	620.98	624.79	606.61	615.45	3.17M
Jan 09, 2026	608.61	622.40	604.55	618.86	2.29M
Jan 08, 2026	612.86	623.36	603.99	606.50	3.14M

Contact Details

Waltham, MA 02451

United States

https://www.thermofisher.com 781 622 1000

About Company

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Stock Peers

MTD

-6.88-0.50%

Mettler-Toledo International Inc.$1,382.85 WAT

-7.44-1.94%

Waters Corporation$376.89 DHR

-3.78-1.72%

Danaher Corporation$215.75 DGX

3.07+1.62%

Quest Diagnostics Incorporated$192.30 CRL

-17.92-8.89%

Charles River Laboratories International, Inc.$183.70 IQV

-21.58-10.65%

IQVIA Holdings Inc.$180.96 A

-3.34-2.51%

Agilent Technologies, Inc.$129.64 RVTY

-4.31-4.15%

Revvity, Inc.$99.52 QGEN

-0.48-0.93%

Qiagen N.V.$51.23 ENZ

-0.0678-17.77%

Enzo Biochem, Inc.$0.31

Company Overview

Thermo Fisher Scientific Inc. (NYSE:TMO) closed at $542.36 USD, losing -$22.86 (-4.04%) from the previous close of $565.22. The stock is currently mid-range between its 52-week high and low $385.46 and $643.99. With a market capitalization of about $203.77 billion, Thermo Fisher Scientific Inc. is classified as a mega-cap and shows market-like volatility (beta ~0.95). Key stats such as the average daily volume over the past year has been around 1.98 million shares, trading with heavier-than-usual volume. Headquartered in Waltham, MA, Thermo Fisher Scientific Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Marc N. Casper, the company employs approximately 125,000 people and listed since March 17, 1980. Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 -10.52%, SMA50 -8.34%, SMA200 8.22%). The stock’s 14-day RSI is 27.71 (weak momentum), while the ATR of 16.29 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -15.78% below its high and over 40.7% above its low. Average 10-day trading volume of 2.69 million shares is slightly above the 3-month average of 1.94 million, indicating heightened recent market interest.

Valuation Metrics

Thermo Fisher Scientific Inc. trades at a P/E ratio of 30.5, slightly below the S&P 500 average, with a price-to-sales ratio of 4.59 and a price-to-book ratio of 3.83 trading at moderately above to book value. The P/FCF stands at 32.52, also above market averages.

Dividend & Fair Value

Thermo Fisher Scientific Inc. last paid a dividend of 1.72 per share, this equals a trailing yield of roughly 0.24%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $467.11. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Thermo Fisher Scientific Inc. generated EPS of $17.74 over the past year. Five-year average earnings growth is 2.11%. Wall Street analysts project EPS growth of 9.12% annually over the next five years. The latest quarter delivered EPS of $5.79. The next quarter is forecast at $5.27. Next year's EPS is expected at $1.21. Analyst sentiment is bullish. Analyst rating data shows there are 18 Strong Buy ratings, 9 Buy ratings, 9 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $750.00 to $450.00. The high target offers 38.28% upside. The low target suggests -17.03% downside. The mean target is $601.92. This offers 10.98% upside. Thermo Fisher Scientific Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 22, 2025, missed forecasts by 5.27%. The prior quarter beat by 2.49%. Over the last six quarters, Apple has recorded several small beats. These include 2.68% in July 24, 2024.

Shareholding & Insider Activity

Thermo Fisher Scientific Inc. has 377.61 million shares outstanding. The public float is 376.74 million shares, elevated short interest at 1.05% of float. This equals 3.94 million shares. The short ratio is 1.95 days. Institutional investors hold 93.06% of the float. Insiders own 0.15%. CASPER MARC N holds 113.76 thousand shares, Lagarde Michel has 84.12 thousand shares and Williamson Stephen has 27.30 thousand shares. Over the past six months, insider transactions show net selling. They sold 90.38 thousand shares across 18 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Thermo Fisher Scientific generated $42.88B in revenue, or $111.96 per share. Gross margin was 42.12%, operating margin 17.11%, and net profit margin 14.77%. Returns are healthy, with ROA at 6.42% and ROE at 13.56%.
On valuation metrics, Thermo Fisher Scientific trades at a P/E of 30.50, P/S of 4.59 and P/B of 3.83. The current ratio is 1.89 and quick ratio is 1.53. Operationally, the company’s inventory turnover is 4.97 and cash conversion cycle is 146.31 days. Debt-to-equity is 0.74, supported by a cash flow-to-debt ratio of 0.20.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2024, Thermo Fisher Scientific posted revenue of $42.88B, down slightly from $42.86B in the prior quarter. Gross profit was $18.06B (margin 42.12%). Operating income was $7.34B (margin 17.1%). Net income was$6.34B (EPS $16.58).
The company ended the quarter with $8.08B in cash and short-term investments, a total debt of $34.92B, and net debt of $26.84B. Total assets were $98.73B, with equity of $46.84B. Financials further reflected stability, with operating cash flow of $8.41B, free cash flow of $6.93B, and capital expenditures of - $1.48B.

Price Forecast & Outlook

Our AI price prediction model suggests that Thermo Fisher Scientific Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.93%, with price expected at $472.21 by February 19, 2026, within a range of $457.21 to $487.46 3-Month Outlook: Projected fall of -41.73%, reaching $316.05 by May 06, 2026, with a range of $296.87 to $331.65. 1-Year Outlook: Projected gain of 1.48%, with price at $550.37 by February 05, 2027, within a range of $527.70 to $571.16.

Key Takeaways

Thermo Fisher Scientific Inc. (NYSE:TMO) shares are flat 6.83% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Thermo Fisher Scientific Inc. trading at a premium to the broader market with a P/E of 30.5. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $609.55, suggesting 12.39% upside. Our AI forecast model points to short-term weakness (-12.93% over two weeks), a medium-term fall (-41.73% over three months), and a longer-term gain (1.48% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Thermo Fisher Scientific Inc. (TMO) stock price?

Thermo Fisher Scientific Inc. (NYSE: TMO) stock price is $542.36 in the last trading session. During the trading session, TMO stock reached the peak price of $566.83 while $541.34 was the lowest point it dropped to. The percentage change in TMO stock occurred in the recent session was -4.04% while the dollar amount for the price change in TMO stock was - $22.86.

TMO's industry and sector of operation?

The NYSE listed TMO is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Thermo Fisher Scientific Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TMO?

Mr. Gianluca Pettiti
Executive Vice President
Mr. Joseph R. Holmes
Vice President & Chief Accounting Officer
Ms. Sandy B. Pound
Vice President & Chief Communications Officer
Dr. Karen E. Nelson Ph.D.
Chief Scientific Officer & Member of Scientific Advisory Board
Mr. Ryan J. Snyder
Senior Vice President & Chief Information Officer
Mr. Rafael Tejada
Vice President of Investor Relations
Mr. Marc N. Casper
Chairman, Pres & Chief Executive Officer
Mr. Stephen Williamson
Senior Vice President & Chief Financial Officer
Mr. Michel Lagarde
Executive Vice President & Chief Operating Officer
Mr. Michael A. Boxer Esq.
Senior Vice President & Gen. Counsel

How TMO did perform over past 52-week?

TMO's closing price is 40.7% higher than its 52-week low of $385.46 where as its distance from 52-week high of $643.99 is -15.78%.

How many employees does TMO have?

Number of TMO employees currently stands at 125,000.

Link for TMO official website?

Official Website of TMO is: https://www.thermofisher.com

How do I contact TMO?

TMO could be contacted at phone 781 622 1000 and can also be accessed through its website. TMO operates from 168 Third Avenue, Waltham, MA 02451, United States.

How many shares of TMO are traded daily?

TMO stock volume for the day was 3.22M shares. The average number of TMO shares traded daily for last 3 months was 1.98M.

What is the market cap of TMO currently?

The market value of TMO currently stands at $203.77B with its latest stock price at $542.36 and 375.71M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	125000
Beta	0.91
Sales or Revenue	$42.88B
5Y Sales Change%	0.832%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Diagnostics & Research

TMO Company Profile and Key Details

Thermo Fisher Scientific

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Shareholding & Insider Activity

Price Forecast & Outlook

Key Takeaways